Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-24

Clinical Trial Update: Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of simeprevir and sofosbuvir in treatment-naïve or experienced adults with chronic genotype 4 hepatitis C; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olysio (Simeprevir)
  • Sovaldi (Sofosbuvir)

Snippet

Sponsor: Peter J. Ruane, M.D. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED